Search

everythinglearnresearchcommunity

for

Search:↓

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Prednisone may cause multiple skin nodules in lupus patients.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Social media can help compare the effectiveness and safety of new arthritis medications.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

High-dose methotrexate can cause severe skin and nail issues.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Muse cells from human bone marrow help reduce symptoms of atopic dermatitis in mice.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

More research is needed to understand and treat morphea effectively.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.